Latigo Biotherapeutics, Inc.

Nasdaq: LTGOMomentum candidate

64 days public · Pharmaceutical Preparations · $16.00 (+8.18%)

Momentum candidate RANKED

/ 100 fit

Confidence100%

Latigo Biotherapeutics, Inc. (LTGO) demonstrates solid momentum-based alignment, scoring 71/100 for the Momentum investment strategy 64 days post-IPO.

Intelligence score

/ 100 core

Suggested alloc

25%

cap · your limits

Days public

EARLY PUBLIC

Last price

$16.00

live quote

1d change

+8.18%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+The 1-day price move of +8.18% actively contributes to the Momentum score of 66.
+Institutional backing is strong with 4 Schedule 13D/13G disclosures on file, driving an Institutional score of 93.
+Active corporate catalysts and insider filing volume (2 8-Ks and 20 insider forms) support a high Narrative score of 78.

RisksLIVE